HIV treatment linked to reduced risk for dry AMD Disclosures: Ambati reports being a co-founder of iVeena Holdings, iVeena Delivery Systems, Inflammasome Therapeutics and DiceRx; has been a consultant for Allergan, Biogen, Boehringer-Ingelheim, Immunovant, Janssen, Olix Pharmaceuticals, Retinal Solutions and Saksin LifeSciences unrelated to this work; and is named as an inventor on patent applications on AMD filed by the University of Virginia or the University of Kentucky. Please see the full study for all other authors’ relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on .